Home/Filings/4/0001179110-20-006521
4//SEC Filing

BRADY ANN 4

Accession 0001179110-20-006521

CIK 0001583107other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 6:05 PM ET

Size

4.4 KB

Accession

0001179110-20-006521

Insider Transaction Report

Form 4
Period: 2020-05-20
BRADY ANN
President, TBIL
Transactions
  • Tax Payment

    Ordinary Shares

    2020-05-20$26.67/sh2,292$61,128102,871 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001767974

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:05 PM ET
Size
4.4 KB